Surprise Q2 Profit Sends Molecular Diagnostic Testing Stock Up 46%

A surprise profit. A turnaround in testing. And a full-year forecast heading north.

Wall Street rose on Wednesday as Apple led a broad tech rally with its massive U.S. investment pledge, while stronger-than-expected quarterly earnings from major companies lifted investor confidence.

Omnicom (NYSE: OMC) just crossed a major milestone in its bid to become the largest advertising and marketing agency in the world.

The U.K.’s competition authority has given the green light to its $13.25 billion all-stock acquisition of Interpublic, removing one of the last major hurdles in a deal that’s expected to finalize later this year.

With regulators in both the U.S. and U.K. on board, the course is now clear for Omnicom to consolidate scale across clients, geographies, and digital platforms.

This gives the company an edge in high-margin segments, such as political ad buying, sports marketing, and global media planning.

For long-term holders, the approval moves Omnicom closer to unlocking meaningful revenue synergies without the delays or concessions often triggered by a Phase 2 review.

Those evaluating an entry point into OMC now have a clearer view as the company is gaining global leverage, defending share from private competitors, and stacking cost advantages across its client services model.

With regulatory barriers removed, clarity in capital allocation may emerge.

This development wasn’t solely about antitrust; it marks a strategic turning point that redefines Omnicom’s position in a fragmented, AI-driven industry.

There’s a new AI movement happening—and it’s not coming out of Silicon Valley.

A select group of U.S.-based companies is laying the infrastructure for how AI will be created, deployed, and monetized in the years to come.

We’ve identified 9 stocks set to benefit most from this trend and compiled them into a free report available for a limited time.

You’ll discover:

These aren’t speculative moonshots. They’re backed by real-world traction and future-focused strategy.

Download the full list now free.

Blackstone (NYSE: BX) is making a $6.5 billion move to expand its role in the energy sector by acquiring Enverus, a Texas-based data and analytics firm used by producers, utilities, and infrastructure operators.

The company provides real-time energy market data, pricing benchmarks, and forecasting tools to over 8,000 customers across 50 countries.

The deal gives Blackstone a strong position in one of the most critical inputs for modern energy operations: decision-grade data.

Enverus collects and processes massive volumes of information from over 40,000 suppliers, encompassing everything from production volumes and drilling activity to emissions tracking and power grid usage.

For shareholders, this acquisition adds a recurring-revenue business tied to the ongoing buildout of U.S. energy infrastructure.

Instead of betting on volatile commodity prices, Blackstone is leaning into software and data tools that energy firms rely on for long-term planning and regulatory compliance.

Those considering exposure to Blackstone may see the deal as part of a broader strategy to acquire businesses with essential roles in high-capital industries.

As energy usage grows, owning the systems that shape operational planning could become a key source of value.

This is not just another asset purchase as Blackstone is positioning itself at the center of how energy companies make decisions and how they stay competitive.

The market is full of noise right now — volatility, trade tensions, and supply chain headaches are dominating headlines.

But amid the turbulence, opportunity is hiding in plain sight.

This exclusive free report reveals 7 stocks strategically positioned to grow in the face of global disruption.

They’re built for this moment — selected from booming sectors, backed by smart data, and supported by strategies professionals are using right now.

If you’re ready to stop reacting and start planning, this guide is for you.

Get your free copy here and uncover the 7 opportunities others are missing.

MercadoLibre's (NASDAQ: MELI) recent stock performance, with shares up nearly 300% in two years, is a powerful signal.

The real story, however, isn't just about past gains, but the company's compelling future.

While the latest earnings report showed revenue up 34%, the slight earnings shortfall was a result of the company's aggressive investments in its ecosystem.

This is a positive sign that management is prioritizing long-term growth over short-term profits.

The company's success is rooted in its ability to dominate the Latin American market through both its e-commerce and FinTech platforms.

The FinTech segment, which grew an impressive 40%, highlights the strength of this dual-engine business model.

A healthy balance sheet and low leverage provide the financial stability to continue this expansion. 

Analysts have taken notice, with a consensus forecast pointing to a 50% upside potential. This perspective is further supported by the high institutional ownership, which accounts for approximately 90% of the stock.

For an investor, these factors signal that the market is beginning to value MercadoLibre not just on its current performance but on the immense potential of its platform.

Despite its impressive run, the company is well-positioned for continued success.

👉 Click here to get our closing report to your cell for free!

Myriad Genetics Inc [MYGN] $5.69 (+46.90%)

Myriad Genetics jumped after a surprise Q2 profit and strong cancer testing sales led the company to raise its full-year guidance.

Grocery Outlet Holding Corp [GO] $18.58 (+42.70%)

Grocery Outlet surged after beating Q2 earnings expectations and raising its full-year profit forecast amid stronger store traffic.

ViaSat Inc [VSAT] $27.83 (+30.72%)

ViaSat climbed after posting better-than-expected Q1 revenue and adjusted earnings, driven by strength in government and defense segments.

LifeMD Inc [LFMD] $6.53 (-44.85%)

LifeMD fell after posting a wider-than-expected Q2 loss and missing revenue estimates, disappointing investors despite strong year-to-date gains.

Evolus Inc [EOLS] $6.37 (-28.51%)

Evolus dropped after missing both earnings and revenue expectations in Q2, continuing a streak of underperformance.

Lantheus Holdings [LNTH] $51.87 (-28.58%)

Lantheus slid after cutting its full-year outlook and missing Q2 revenue and earnings estimates amid increased competition in imaging, overshadowing recent FDA filing news.

U.S.-China trade tensions. Disrupted supply chains. Shifting global demand.

These macro forces are reshaping the investment landscape.

But amidst the uncertainty, a handful of companies are quietly gaining momentum.

Our team has identified seven stocks that are not just surviving—they’re positioned to thrive.

Backed by real data and forward-looking analysis, this new report highlights which industries are heating up—and which ones to watch closely.

Whether you're an active trader or a long-term investor, this free guide delivers strategic clarity for volatile times.

Click here to access your free report and uncover what’s moving now.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.